SUMMARY
- Mosaic raised $47 million in seed funding.
- The funds will support its growth.
- Mosaic develops robotic tools for surgery.
Mosaic Intelligence Labs, a San Francisco, CA-based provider of sensing-enabled spatial intelligence and robotic infrastructure to help physicians understand and safely navigate the body from within, has raised $47 million in a seed funding round.
The round saw backers including 8VC, Fundomo, Lingotto Innovation, and Obvious Ventures.
The company will use the funding to expand its operations, advance product development and hire engineers, physicians and creatives across hardware engineering, sensing, perception, machine learning and clinical engineering.
What is Mosaic Intelligence Labs?
Mosaic Intelligence Labs is developing technology to help physicians understand and navigate the human body during surgery.
Read More:Texas-Based Triplemoon Secures $4M in Seed Extension Funding
The company is initially focusing on endovascular procedures, in which doctors guide flexible wires and catheters through blood vessels to treat medical conditions.
Today, physicians rely on live X-ray images, preoperative scans and the physical feedback from surgical instruments to understand their position inside the body. Interpreting this information requires years of experience.
Mosaic aims to improve this process by giving surgical instruments their own sensing capabilities. Its technology combines sensors with advanced computing to build a continuously updated, three-dimensional view of blood vessels, surrounding anatomy and instrument positions.
RECOMMENDED FOR YOU
Funding Wrap of the Week | North American Startups Funding Roundup | March 17 – March 22
Devin Jacobs
Mar 23, 2024
How Much Funding Has Mosaic Intelligence Labs Raised?
Mosaic Intelligence Labs has raised $47 million in its seed funding round. The company has not disclosed its total funding raised or details of previous investment rounds.
Who Invested in Mosaic Intelligence Labs’ Seed Round?
The $47 million seed round included participation from:
- 8VC
- Fundomo
- Lingotto Innovation
- Obvious Ventures
The company did not disclose a lead investor for the round.
Why the Funding Matters
Mosaic Intelligence Labs will use the funding to expand its operations and continue developing its sensing and robotic technologies.
The company also plans to recruit talent across hardware engineering, sensing, perception, machine learning and clinical engineering.
These investments will support its work on surgical systems that combine real-time sensing, spatial intelligence and robotic control.
Who founded Mosaic Intelligence Labs?
Mosaic Intelligence Labs was founded in 2025 by Ileana Pirozzi and Alison Mackanic. Both founders are Stanford-trained scientists.
The company is headquartered in San Francisco, California.
“We spent years in operating rooms watching extraordinary people do extraordinary things. But what really stayed with us was just how much depended on knowledge that lived in the hands and minds of the person holding the instrument,” said Dr. Ileana Pirozzi, co-founder and CEO of Mosaic.
“There is no evolving loop between perception and action, and as a result they are structurally locked out of the ability to become intelligent,” said Mackanic, co-founder and CTO of Mosaic.
Market and Business Growth
Mosaic is starting with endovascular intervention, a field where physicians use wires and catheters to reach different parts of the body through blood vessels.
The company is developing infrastructure that captures information about anatomy, instrument movement and physician actions. It combines this information with physical models to help machines understand their surroundings and how their movements affect them.
Its long-term approach is to make surgical experience a source of continuous learning, helping improve how machines support physicians during procedures.
What Happens Next?
Mosaic plans to expand its engineering and clinical teams while continuing to develop its sensing-enabled instruments, spatial intelligence platform and robotic systems.
The company will initially focus on endovascular procedures, with the broader goal of helping physicians perform more complex treatments through the vascular system.
Read More:Lumbra Secures $25M in Series A Funding








